Can echocardiography identify mildly hypertensive patients at high risk, left untreated based on current guidelines?

Journal of Hypertension

Volumn 17, Issue 6, 1999, Pages 817-824

  Abergel, Eric ^a,b   Chatellier, Gilles ^b   Battaglia, Christiane ^a   Menard, Joël ^a  

^a Centre d'Investigation Clinique   (France)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

Left ventricular concentric remodelling; Mild hypertension; WHO ISH guidelines

Indexed keywords

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BORDERLINE HYPERTENSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GEOMETRY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WORLD HEALTH ORGANIZATION;

EID: 0032992115     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917060-00014     Document Type: Article

References (36)

1. 1 Guidelines for the treatment of mild hypertension. Memorandum from a WHO/ISH Meeting. J Hypertens 1993; 11:905-918.
2. 2 The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Bethesda, Maryland: National Heart, Lung, and Blood Institute, 1997. NIH Publication 98-4080.
3. 3 Management Committee of the Australian Therapeutic Trial in Mild Hypertension. Untreated mild hypertension. Lancet 1982; i; 185-191.
4. 4 Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993; 306:983-987.
5. 5 Davis CE. The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol 1976; 104:493-498.
6. 6 Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and mota-analysis. JAMA 1997; 277:739-745.
7. 7 Bikkina M, Levy D, Evans JC, Larson MG, Benjamin EJ, Wolf PA, et al. Left ventricular mass and risk of stroke in an elderly cohort, the Framingham study. JAMA 1994; 272:33-36.
8. 8 Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322:1561-1566.
9. 9 Liao Y, Cooper RS, Durazo-Arvizu R, Mensah GA, Ghali JK. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997; 29:641-647.
10. 10 Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995; 25:878-884.
11. 11 Koren MJ, Deveroux RB, Casalo PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-352.
12. 12 Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal ventricular mass. J Am Coll Cardiol 1995; 25:871 -878.
13. 13 Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1990; 121:293-298.
14. 14 Schillaci G, Verdecchia P, Borgioni C, Ciuuci A, Guerrieri M, Zampi I, et al. Improved electrocardiographic diagnosis of left ventricular hypertrophy. Am J Cardiol 1994; 74:714-719.
15. 15 Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension 1987; 9 (Suppl. II):1119-1126.
16. 16 Abergel E, Cohen A, Vaur L, Khellaf F, Menard J, Chatellier G. Accuracy and reproducibility of left ventricular mass measurement by subcostal M-mode echocardiography in hypertensive patients and professional bicyclists. Am J Cardiol 1993; 72:620-624.
17. 17 Schiller NB, Shah PM, Crawford M, De Maria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
18. 18 Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
19. 19 de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 1994; 23:600-606.
20. 20 Moser M. Can the cost of care be contained and quality of care maintained in the management of hypertension? Arch Intern Med 1994; 154:1665-1672.
21. 21 Abergel E, Tase M, Bohlender J, Menard J, Chatellier G. Which definition for echocardiographic left ventricular hypertrophy? Am J Cardiol 1995; 75:498-502.
22. 22 Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986; 7:639-650.
23. 23 Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA, et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the treatment of mild hypertension study (TOMHS). Circulation 1993; 87:476-486.
24. 24 Jackson R, Barahm P, Bills J, Birch T, McLennan L, MacMahon S, et al. Management of raised blood pressure in New Zealand: a discussion document, BMJ 1993; 307:107-110.
25. 25 Post WS, Larson MG, Levy D. Impact of left ventricular structure on the incidence of hypertension. The Framingham heart study. Circulation 1994; 90:179-185.
26. 26 Verdecchia P, Porcellati C, Zampi I, Schillaci G, Gatteschi C, Battistelli M, et al. Asymmetric left ventricular remodeling due to isolated septal thickening in patients with systemic hypertension and normal left ventricular masses. Am J Cardiol 1994; 73:247-252.
27. 27 Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19:1550-1558.
28. 28 Ganau A, Saba PS, Roman MJ, de Simone G, Realdi G, Devereux RB. Ageing induces left ventricular concentric remodelling in normotensive subjects. J Hypertens 1995; 13:1818-1822.
29. 29 Sumimoto T, Mukai M, Murakami E, Kokubu T, Lin M, Shigematsu Y, et al. Effect of age on left ventricular geometric patterns in hypertensive patients. J Hypertens 1995; 13:1813-1817.
30. 30 Ghali JK, Liao Y, Cooper RS. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol 1998; 31:1635-1640.
31. 31 Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol 1996; 78:197-202.
32. 32 ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 1997; 95:1686-1744.
33. 33 Alderman MH. Blood pressure management: individualized treatment based on absolute risk and the potential for benefit. Ann Intern Med 1993; 119:329-335.
34. 34 Ḿenard J, Chatellier G. Mild hypertension: the mysterious viability of a faulty concept. J Hypertens 1995; 13:1071-1077.
35. 35 West of Scotland Study Group. Influence of pravastatin and plasma lipids on clinical events in the west of Scotland coronary prevention study (WOSCOPS). Circulation 1998; 97:1440-1445.
36. 36 Sheps SG, Frolich ED. Limited echocardiography for hypertensive left ventricular hypertrophy. Hypertension 1997; 29:560-563.